Evaluation of the New VITEK 2 System for Determination of the Susceptibility of Clinical Isolates of Streptococcus pneumoniae

Publisher： Karger

E-ISSN： 1421-9794|48|1|26-30

ISSN： 0009-3157

Source： Chemotherapy, Vol.48, Iss.1, 2010-10, pp. : 26-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determination of the Pharmacodynamic Profile of Daptomycin against Streptococcus pneumoniae Isolates with Varying Susceptibility to Penicillin in a Murine Thigh Infection Model

By  

Chemotherapy, Vol. 50, Iss. 1, 2004-04 ,pp. : 11-16

Karger

Access to resources Recommend Favorite

The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000

By  

Chemotherapy, Vol. 48, Iss. 5, 2002-12 ,pp. : 232-237

Karger

Access to resources Recommend Favorite

Activity of Moxifloxacin and Twelve Other Antimicrobial Agents against 216 Clinical Isolates of Streptococcus pneumoniae

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-02 ,pp. : 90-96

Karger

Access to resources Recommend Favorite

Serotype Distribution and Antimicrobial Resistance of Adult Streptococcus pneumoniae Clinical Isolates over the Period 2001–2008 in Crete, Greece

By  

Chemotherapy, Vol. 56, Iss. 4, 2010-08 ,pp. : 325-332

Karger

Access to resources Recommend Favorite

Ten-Year Trends and Clinical Relevance of the Antimicrobial Resistance Genotype in Respiratory Isolates of Streptococcus pneumoniae

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-05 ,pp. : 256-261

Karger

Access to resources Recommend Favorite